Fusion Antibodies is delighted to be attending Discovery on Target 2022.

This event will be delivered in Boston  from 17-20th October 2022.

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Get in touch below to organise a meeting with one of the Fusion Antibodies team.

About Fusion Antibodies 

Fusion Antibodies are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics to clinical Cell Line Development.

We have guided hundreds of projects through critical pre-clinical stages, repeatedly proving our expertise as we strive to bring about a positive change in the healthcare industry.